Simonian Nancy A
Insider CIK 1359574 · SGEN Director · SYRS President and CEO, Director · EVLO Director · GENB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines, Inc | A Award deriv | 2026-02-26 | 2026-03-02 | 29,561 | — | $0 | 29,561 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-12-02 | 2024-12-04 | 37,070 | $0.27 | $10.0K | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-11-25 | 2024-11-27 | 134,713 | $0.27 | $36.4K | 41,070 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-10-31 | 2024-11-04 | 40,125 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-10-31 | 2024-11-04 | 40,125 | — | $0 | 175,783 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 135,658 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-04-01 | 2024-04-02 | 14,052 | $5.12 | $71.9K | 131,658 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 6,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 39,566 | — | $0 | 79,134 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 39,566 | — | $0 | 145,710 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 6,000 | — | $0 | 106,144 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,676 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,462 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,171 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 7,038 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 2,044 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 8,750 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer | 2023-12-14 | 2023-12-15 | 62,753 | $229.00 | $14.37M | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | D To issuer deriv | 2023-12-01 | 2023-12-05 | 28,001 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | D To issuer deriv | 2023-12-01 | 2023-12-05 | 29,399 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | D To issuer deriv | 2023-12-01 | 2023-12-05 | 30,399 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | D To issuer deriv | 2023-12-01 | 2023-12-05 | 17,499 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | D To issuer deriv | 2023-12-01 | 2023-12-05 | 7,500 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-11-01 | 2023-11-02 | 13,401 | $2.22 | $29.8K | 100,144 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-10-31 | 2023-11-02 | 40,125 | — | $0 | 40,125 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-10-31 | 2023-11-02 | 40,125 | — | $0 | 113,545 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,044 | — | $0 | 64,797 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-04-03 | 2023-04-04 | 1,852 | $2.58 | $4.8K | 73,420 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-03-31 | 2023-04-04 | 6,000 | — | $0 | 18,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-03-31 | 2023-04-04 | 6,000 | — | $0 | 75,272 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-02-16 | 2023-02-21 | 118,700 | — | $0 | 118,700 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-12-12 | 2022-12-14 | 8,750 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-12-12 | 2022-12-14 | 8,750 | $36.70 | $321.1K | 62,753 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 80,250 | — | $0 | 80,250 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 115,000 | — | $0 | 115,000 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2022-05-13 | 2022-05-17 | 3,676 | — | $0 | 3,676 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2022-05-13 | 2022-05-17 | 1,503 | — | $0 | 54,003 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2022-04-01 | 2022-04-04 | 58,883 | $1.12 | $65.9K | 692,723 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-03-02 | 2022-03-04 | 25,000 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-03-02 | 2022-03-04 | 25,000 | $20.04 | $501.0K | 52,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 375,000 | — | $0 | 375,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 3,462 | — | $0 | 3,462 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2021-05-14 | 2021-05-18 | 1,402 | — | $0 | 27,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-02-17 | 2021-02-19 | 304,000 | — | $0 | 304,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2020-12-18 | 2020-12-21 | 10,761 | — | $0 | 21,524 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2020-12-18 | 2020-12-21 | 14,168 | — | $0 | 79,165 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2020-12-18 | 2020-12-21 | 4,988 | — | $0 | 280,012 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2020-12-18 | 2020-12-21 | 10,761 | $3.04 | $32.7K | 544,450 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2020-12-18 | 2020-12-21 | 14,168 | $8.51 | $120.6K | 558,618 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2020-12-18 | 2020-12-21 | 4,988 | $10.09 | $50.3K | 563,606 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 15,690 | — | $0 | 15,690 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2020-05-15 | 2020-05-19 | 3,171 | — | $0 | 3,171 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2020-05-15 | 2020-05-19 | 1,335 | — | $0 | 26,098 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-02-13 | 2020-02-14 | 294,000 | — | $0 | 294,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2019-12-23 | 2019-12-23 | 33,429 | — | $0 | 1,037,095 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2019-12-23 | 2019-12-23 | 10,762 | — | $0 | 1,026,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2019-12-23 | 2019-12-23 | 8,210 | — | $0 | 1,018,123 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2019-12-23 | 2019-12-23 | 52,401 | $3.04 | $159.3K | 533,689 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,690 | — | $0 | 15,690 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2019-05-20 | 2019-05-22 | 7,038 | — | $0 | 7,038 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2019-05-20 | 2019-05-22 | 2,963 | — | $0 | 24,763 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 285,000 | — | $0 | 285,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2019-02-12 | 2019-02-14 | 188,000 | — | $0 | 669,288 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2018-11-29 | 2018-12-03 | 23,454 | — | $0 | 872,657 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2018-11-29 | 2018-12-03 | 12,084 | — | $0 | 785,523 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2018-11-29 | 2018-12-03 | 75,050 | — | $0 | 797,607 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2018-11-29 | 2018-12-03 | 12,084 | $3.04 | $36.7K | 481,288 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2018-11-29 | 2018-12-03 | 98,504 | $1.01 | $99.5K | 469,204 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2018-05-18 | 2018-05-22 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2018-05-18 | 2018-05-22 | 3,700 | — | $0 | 21,800 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2018-05-08 | 2018-05-10 | 31,380 | — | $0 | 31,380 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-02-16 | 2018-02-21 | 285,000 | — | $0 | 285,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2017-05-19 | 2017-05-23 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2017-05-19 | 2017-05-23 | 3,700 | — | $0 | 18,100 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-02-10 | 2017-02-13 | 175,000 | — | $0 | 175,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-16 | 2016-09-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 250,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 66,666 | — | $0 | 370,702 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2016-05-20 | 2016-05-24 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2016-05-20 | 2016-05-24 | 3,700 | — | $0 | 14,400 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2015-05-15 | 2015-05-19 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2015-05-15 | 2015-05-19 | 3,700 | — | $0 | 10,700 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2014-05-16 | 2014-05-20 | 8,750 | $34.25 | $299.7K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2014-05-16 | 2014-05-20 | 3,500 | — | $0 | 7,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2013-05-17 | 2013-05-21 | 8,750 | $36.70 | $321.1K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2013-05-17 | 2013-05-21 | 3,500 | — | $0 | 3,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2012-03-19 | 2012-03-21 | 25,000 | $20.04 | $501.0K | 25,000 | SEC↗ |